Daniel Chevallard
Equibles does not estimate personal net worth.
Get an email with a short summary when LENZ Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get LENZ alertsAbout Daniel Chevallard
Daniel Chevallard is recorded as CEO at LENZ Therapeutics, Inc. (LENZ) since December 1, 2026 and CFO at LENZ Therapeutics, Inc. (LENZ). The newest filing on record that lists Daniel Chevallard as CFO at LENZ Therapeutics, Inc. (LENZ) is dated April 28, 2026. LENZ Therapeutics, Inc. reported in an 8-K filed October 28, 2026 that Daniel Chevallard was appointed Interim President and CEO, effective December 1, 2026. LENZ Therapeutics, Inc. reported in an 8-K filed March 22, 2024 that Daniel Chevallard was appointed Chief Financial Officer, effective March 21, 2024. The proxy statement of LENZ Therapeutics, Inc. reports total compensation of $3,063,051 for Daniel Chevallard in fiscal 2024, including a base salary of $376,808. LENZ Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at LENZ Therapeutics, Inc. includes Kimberlee C. Drapkin (CEO, CFO, Chief Accounting Officer and Board Member), Jeff George (Chairman and Board Member), Mr. George (Chairman) and 6 others.
“In connection with the transition described above, on October 28, 2026, the Board appointed Daniel Chevallard, the Company’s Chief Financial Officer, to serve as the Company’s Interim President and CEO and principal executive officer replacing Mr. Schimmelpennink in such roles, effective as of the CEO Transition Date.”
“on March 21, 2024, the Board appointed Daniel Chevallard as the Company’s Chief Financial Officer.”
Affiliation history
-
Current
2026-12-01–present
-
Current
Start not stated–present
Last confirmed April 28, 2026
Company network
Leadership on record at LENZ Therapeutics, Inc.
- Kimberlee C. Drapkin CEO, CFO, Chief Accounting Officer, Board Member
- Jeff George Chairman, Board Member
- Mr. George Chairman
- Katherine V. Stultz COO
- Continuing Directors Board Member
- Frederic Guerard Board Member
- James McCollum Board Member
- Shelley Thunen Board Member
- Zach Scheiner Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | LENZ Therapeutics, Inc. (LENZ) | Chief Financial Officer | $376,808 | $3,063,051 |